Skip to content

Microdosing research published in 2020

21 studies whose primary subject is microdosing were published in 2020, up from 16 in 2019. Newest first. Back to the microdosing overview

Studies

Author response: Self-blinding citizen science to explore psychedelic microdosing

December 11, 2020 Balázs Szigeti, Laura Kärtner, Allan Blemings et al. 1 citation

Psychedelic psychotherapy, therapy enhanced with psychedelic drugs such as LSD or psilocybin (the active ingredient of ‘magic mushrooms’), has been suggested to improve psychological well-being. For this reason, trials on psychedelic therapy for the treatment of depression, addiction and other conditions are ongoing. Recently, ‘microdosing’ – a way of administering psychedelics that involves...

Farmers' Soil Fertility Management in Niger and Opportunities for Improvements Through Mechanization, Microdosing, and Seed Coating

Frontiers in Sustainable Food Systems December 8, 2020 Abdourahamane Issa M. Nourou, Addam Kiari Saidou, Jens B. Aune

The objective of this study was to characterize pearl millet production in Niger and to assess the potential impact of a low-cost production package on land- and labor productivity. The survey showed that 62% of the farmers used manure, while 22% used mineral fertilizer. Of those who used mineral fertilizer only 18% practiced microdosing. High labor demand was given as the reason why 89% of the...

Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing

Transplantation Direct October 26, 2020 Hari V. Kalluri, Puneet Sood, Wenchen Zhao et al.

Background. Renal transplantation is the treatment of choice for patients with end-stage renal disease. Because kidneys are the primary excretory organs for various drugs/drug metabolites, changes in renal graft function would significantly alter the clearance and exposure of renally secreted drugs. Renal allografts from living and deceased donors normally undergo numerous insults, including...

Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study

Journal of the American College of Emergency Physicians Open October 20, 2020 J. Moe, K. Badke, Megan Pratt et al.

Emergency department (ED)–initiated buprenorphine may prevent overdose. Microdosing is a novel approach that does not require withdrawal, which can be a barrier to standard inductions. We aimed to evaluate the feasibility of an ED‐initiated buprenorphine/naloxone program providing standard‐dosing and microdosing take‐home packages and of randomizing patients to either intervention.

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

Journal of Psychopharmacology October 8, 2020 Rotem Petranker, Thomas Anderson, Larissa J. Maier et al. 57 citations

Background: Microdosing psychedelics is the practice of taking small, sub-hallucinogenic doses of lysergic acid diethylamide or psilocybin-containing mushrooms. Despite its surging popularity, little is known about the specific intentions to start microdosing and the effects of this practice. Aims: First, we aimed to replicate previous findings regarding the subjective benefits and challenges...

Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review

Neuroscience & Biobehavioral Reviews October 5, 2020 Genís Ona, José Carlos Bouso 59 citations

Microdosing psychedelic drugs-that is, taking sub-behavioral doses of lysergic acid diethylamide (LSD) or psilocybin-is a growing practice in Western societies. Taken mainly for creative or mood-enhancing purposes, thousands of users are increasingly being exposed to (micro)doses of psychedelic drugs. In this systematic review, we searched the available evidence from human studies, focusing our...

Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine–Naloxone Through Microdosing: A Case Report

A&A Practice September 21, 2020 Isaiah T. Crum, VaKara M. Meyer Karre, Alëna A. Balasanova

A 76-year-old woman with chronic noncancer pain and an intrathecal hydromorphone–bupivacaine pump was admitted for acute exacerbation of heart failure. Her pump was unable to be replaced due to medical comorbidities. She was unable to tolerate oral opioids due to ventilatory depression. Tapering hydromorphone resulted in opioid withdrawal due to physiological dependence. Microdosing of...

Phase 0/microdosing approaches: time for mainstream application in drug development?

Nature Reviews Drug Discovery September 8, 2020 Tal Burt, Graeme C. Young, Wooin Lee et al. 101 citations

Phase 0 approaches - which include microdosing - evaluate subtherapeutic exposures of new drugs in first-in-human studies known as exploratory clinical trials. Recent progress extends phase 0 benefits beyond assessment of pharmacokinetics to include understanding of mechanism of action and pharmacodynamics. Phase 0 approaches have the potential to improve preclinical candidate selection and...

Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans

Pharmaceuticals August 1, 2020 Michael Wagner, Johan G. Doverfjord, Joachim Tillner et al.

Introduction: [68Ga]Ga-DO3A-VS-Cys40-Tuna-2 (previously published as [68Ga]Ga-DO3A-VS-Cys40-S01-GCG) has shown high-affinity specific binding to the glucagon receptor (GCGR) in vitro and in vivo in rats and non-human primates in our previous studies, confirming the suitability of the tracer for drug development applications in humans. The manufacturing process of [68Ga]Ga-DO3A-VS-Cys40-Tuna-2...

DOI: 10.3390/ph13080176 (opens in new tab) Full text (opens in new tab) Glucagon receptor Diabetes Gmp Gallium-68 +2

A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients

Journal of Nuclear Medicine July 17, 2020 O. Kulterer, S. Pfaff, Wolfgang Wadsak et al.

99mTc-PHC-102 is a 99mTc-labeled derivative of acetazolamide, a high-affinity small organic ligand of carbonic anhydrase IX (CAIX). 99mTc-PHC-102 has previously shown favorable in vivo biodistribution properties in mouse models of CAIX-positive clear cell renal cell carcinoma (ccRCC) and colorectal cancer. In this study, we aimed to explore the targeting performance of 99mTc-PHC-102 in SPECT in...

Factors driving cereal response to fertilizer microdosing in sub‐Saharan Africa: A meta‐analysis

Agronomy Journal July 1, 2020 Yacouba Ouedraogo, Jean‐Baptiste Sibiri Taonda, Idriss Sermé et al.

Abstract: Fertilizer microdosing (FM) is being promoted in sub‐Saharan Africa (SSA) to boost crop productivity on smallholder farms. However, yield response variability is a barrier to adoption. We conducted a meta‐analysis to analyze the variability in cereal crop yield response to FM and to determine the main factors associated with this variability. Thirty publications pertaining to millet...

Microdosing as a response to the meaning crisis

May 26, 2020 Rotem Petranker, Juensung J. Kim, Thomas Anderson 4 citations preprint

Background: The use of psychedelic substances like LSD and magic mushrooms in research and to treat mental health conditions has been increasing in the last decade. In particular, the practice of microdosing – using sub-hallucinogenic amounts of psychedelics – has been increasing (Anderson et al., 2019), but large-scale systemic qualitative analyses are still scant.Aims: This study attempted to...

DOI: 10.31234/osf.io/2jnkf (opens in new tab) Meaning existential Microdose Disappointment Pharmacology +1

Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.

Psychopharmacology May 1, 2020 Toby Lea, Nicole Amada, Henrik Jungaberle et al.

The regular consumption of very small doses of psychedelic drugs (known as microdosing) has been a source of growing media and community attention in recent years. However, there is currently limited clinical and social research evidence on the potential role of microdosing as therapies for mental and substance use disorders. This paper examined subjective experiences of microdosing...

Intensification of Pearl Millet Production in Niger through Mechanized Sowing and Weeding, Seed Priming, Seed Treatment, and Microdosing

Agronomy April 29, 2020 Abdourahamane Issa M. Nourou, Addam Kiari Saidou, Warouma Arifa et al.

Pearl millet production in Niger is characterized by manual sowing and weeding and low use of inputs like mineral and organic fertilizer. This objective of the study was to compare a traditional production package (control) against a new production package consisting of mechanized sowing and weeding, seed priming, seed treatment with a fungicide/insecticide, and microdosing at rate of 0.3 g NPK...

A Chemical Love Story: Considering Microdosing as Somatechnic Individuation Vis-à-Vis the Philosophy of Simondon

Somatechnics April 1, 2020 Chantelle Gray

Research shows that due to rapidly changing higher education contexts, large numbers of academics are overworked, stressed, and dispirited. This is exacerbated by the fact that most academics do not view academia simply as work, but as a vocation. To deal with these conditions, the use of cognitive modification and enhancement drugs have become far more prevalent than used to be the case. In...

Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities

Journal of Psychopharmacology February 28, 2020 Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson et al. 75 citations

Rationale: Microdosing psychedelics – the practice of consuming small, sub-hallucinogenic doses of substances such as LSD or psilocybin – is gaining attention in popular media but remains poorly characterized. Contemporary studies of psychedelic microdosing have yet to report the basic psychiatric descriptors of psychedelic microdosers. Objectives: To examine the practices and demographics of a...

Psychedelic Microdosing: Prevalence and Subjective Effects

Journal of Psychoactive Drugs January 23, 2020 Lindsay P. Cameron, Angela Nazarian, David E. Olson 112 citations

Anecdotal reports suggest that the administration of sub-hallucinogenic doses of psychedelic compounds on a chronic, intermittent schedule – a practice known as psychedelic microdosing – is becoming increasingly popular among young adults due to its purported ability to reduce symptoms of depression and anxiety while improving cognitive function and promoting social interaction. Using an...

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Addiction Science & Clinical Practice January 19, 2020 Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo et al.

Abstract Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a high-risk patient with a history of failed initiations due, in part, to withdrawal symptoms. Using an assertive outreach model and a...

Rapid Induction of Buprenorphine/Naloxone for Chronic Pain Using a Microdosing Regimen: A Case Report

A&A Practice January 15, 2020 Danny S. Lee, Jessica E. Hann, Sukhpreet Klaire et al.

Buprenorphine is an effective treatment for chronic pain and may reduce opioid-induced hyperalgesia. However, its pharmacological properties make its induction challenging, time-consuming, and can precipitate opioid withdrawal. We present the case of a 66-year-old woman with inadequately controlled postoperative pain despite escalating doses of oxycodone and methadone, who was successfully...

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.

Journal of Psychoactive Drugs 2020 Joel Bornemann

Psychedelic substances are currently experiencing a renaissance in interest for both therapeutic as well as recreational applications. It has been proposed that microdosing, i.e., ingesting sub-perceptual doses of a psychedelic, could confer some of the benefits of these substances to users while minimizing the risks associated with full-dose use. This review aimed to summarize and examine the...